A Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ACE-031 in Healthy Postmenopausal Women

Clinical trial NCT00952887 · COMPLETED

Trial details

NCT number: NCT00952887
Sponsor: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Muscular Atrophy

Start date: 2009-08-01
Primary completion: 2011-02-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.